A Pivotal Clinical Trial of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Injection (HiCM-188) for the Treatment of Advanced Heart Failure(NYHA III-IV)

NCT07496372 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

BIOLOGICAL: HiCM-188 therapy
PROCEDURE: CABG surgery

Sponsor

HELP Therapeutics Co., Ltd.